Clinical Trial Update: Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of empagliflozin and pioglitazone in patients with type 2 diabetes and non-alcoholic fatty liver disease. Status not discl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Non-Alcoholic Fatty Liver Disease, Type2diabetes | Phase 4 | Status: UNKNOWN